2Terry TL.Extreme prematurity and fibroplastic overgrowth of persistent vascular sheath behind each crysralline lens.Am J Ophthalmol 1942;25(4):203-209.
3Modrzejewska M.Retinopathy of prematurity-pathogenesis and prevalence.Ann Acad Med Stetin 2006;52(1):67-72.
4Wallace DK,Veness-Meehan KA,Miller WC,et al.Incidence of severe retinopathy of prematurity before and after a modest reduction in target oxygen saturation levels.J AAPOS 2007;11(2):170-174.
5Engel RR,Oden NL,Cohen GR,et al.Influence of prior assignment on refusal rates in a trial of supplemental oxygen for retinalpathy of prematurity.Paediatr Perinat Epidemiol 2006;20(4):348-359.
6Ozdemir M,Koylu S.Ocular growth and morbidity in preterm children without retinopathy of prematurity.Jpn J Ophthalmol 2009;53(6):623-628.
7Penn JS,Tolman BL,Ballard LE.Effect of a water-soluble vitamin E anolog,trolox C,on retinal vascular development in an animal model of retinipathy of prematurity.Free Radic Biol Med 1997;22(6):977-984.
8Papp A,Nemeth I,Karg E,et al.Glutathione status in retinapathy of prematurity.Free Radic Biol Med 1999;27(7-8):738-743.
9Chen J,Smith LE.Retinopathy of prematurity.Angiogenesis 2007;10(2):133-140.
10Hardy P,Dumont I,Bhattacharya M,et al.Oxidants,nitric oxide and prostanoids in the developing ocular vasculature:a basis for ischemic retinopathy.Cardiovasc Res 2000;47(3):489-509.
